About: Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'agostu de 2019 (ast) scientific article published on 01 August 2019 (en) im August 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована 1 серпня 2019 (uk)
publication date	wds:Q91996253-2B845B17-1695-4BAB-A158-EAE334022A90
publication date	2019-08-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q91996253-0C049A92-2378-4776-B91E-3EEB86BAC207 wds:Q91996253-2E124467-E165-41F5-B3F4-7CD5FC4F9BC8 wds:Q91996253-3ED7A2D2-385F-4174-A656-39ABBE53A775 wds:Q91996253-431F3641-315E-4E52-A160-67646447C7A0 wds:Q91996253-47AAA19E-C7E8-4BA0-B085-793439D04CB4 wds:Q91996253-4D3AEB45-89FF-4F35-AA50-D68F054189C7 wds:Q91996253-56275149-A272-4FCD-9956-55B45288E1DF wds:Q91996253-66D822D9-B999-4B00-B932-481A88FAF8FF wds:Q91996253-6B2D5157-8CC2-49FD-A17B-B5278B07318A wds:Q91996253-72B6D5D2-3CD2-449F-9188-B0AED45FB73F wds:Q91996253-87696F32-900A-46AA-9357-F7C6FC03F553 wds:Q91996253-9828699D-F020-4E2B-8411-4B96BEEF4646 wds:Q91996253-A466310D-2563-4F54-84C1-C50E2A37D00A wds:Q91996253-B6EE66CE-FF2C-464B-85EC-DC940B01F3FC wds:Q91996253-C6C0F145-CFD8-4E7F-9DF2-B1C3D9062993 wds:Q91996253-C7AFB29E-4676-4693-A5A7-D432275A2D2A wds:Q91996253-DA6DE01E-C774-4CA4-BB67-CCC8047C97FC wds:Q91996253-E6852404-3908-4C4F-994D-3DFB70DAE230 wds:Q91996253-EF3EE2D8-DB97-4EA9-A9A2-F5315330A247 wds:Q91996253-F731233D-28F0-483C-9F50-AF77C4840E39 wds:Q91996253-F7F37D45-E77F-47F8-A65E-F6D79FC85234 wds:Q91996253-FA80945F-28ED-49C7-BA16-37567B1DE0FC
cites work	BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression. Anaplastic thyroid carcinoma: pathogenesis and emerging therapies Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid Carcinoma. BRAF V600E inhibition in anaplastic thyroid cancer. Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer. Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma. Response to Targeted Therapy in BRAF Mutant Anaplastic Thyroid Cancer.
author name string	wds:Q91996253-10DDDB7D-864A-4A60-AB62-71471ADE7632 wds:Q91996253-11687510-6882-425B-979E-FF72EE397B72 wds:Q91996253-3E23A680-81E8-4D1F-8558-4798EC013402 wds:Q91996253-518059B1-3C98-43EB-898C-D3EF6897756B wds:Q91996253-54B8A0E8-189E-4561-8514-A1412B5C3BA9 wds:Q91996253-55DA1AF1-1C43-48E6-B605-022522F9FBC5 wds:Q91996253-8C07EDD3-4A67-4017-ACFD-39760C8469E6 wds:Q91996253-9CA02D46-6ADA-4673-B6A4-4F8677B29718 wds:Q91996253-9FB66883-8D3F-478B-91E8-7B1EC6711C09 wds:Q91996253-B7D6998C-7DC2-4255-BF03-8465B526B121 wds:Q91996253-BD434043-FADD-449C-ADF2-EAEB4A5C706E wds:Q91996253-C27169C1-80FA-4D5E-9041-01C80079FB59 wds:Q91996253-C6A74C68-7D27-417B-ACFD-55F713559BBD wds:Q91996253-D5E9E07D-872E-4BBD-A84C-1FEB637B5579 wds:Q91996253-DFC3B3DD-79F7-497B-B151-DEB23AAF7D54 wds:Q91996253-E849C83B-B5D3-4AF8-A48A-014507E650C5 wds:Q91996253-E8D579F7-5227-4113-86C7-8EBAB6A40A46 wds:Q91996253-F1208AF7-6F83-466C-A896-1980FCAEA16B wds:Q91996253-F9DF1D98-43BD-4D24-90EF-26DD9FBEC411
author name string	Michelle D Williams Charles Lu Neil D Gross Maria E Cabanillas William H Morrison Erich M Sturgis Stephen Y Lai David I Rosenthal Salmaan Ahmed Jack Phan Clifton David Fuller Mark E Zafereo Renata Ferrarotto Ramona Dadu Naifa L Busaidy Priyanka Iyer Maria K Gule-Monroe Ryan P Goepfert Jennifer R Wang
rdfs:label	Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma (en) Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma (nl)
skos:prefLabel	Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma (en) Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma (nl)
name	Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma (en) Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma (nl)
author	wds:Q91996253-7BE35D7A-CF29-4B2F-8482-D85B50287AE6
author	G Brandon Gunn
title	wds:Q91996253-C1BA3592-C08D-443A-9895-8FECB442796C
title	Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software